2025-03-29 18:16:22
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Zim Laboratories consolidated Q4 FY2022 net profit soars to Rs. 7.03 crores
Posted On : 2022-05-21 22:14:26( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 106.6909 crores during the period ended March 31, 2022 as compared to Rs. 87.4007 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 7.0302 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 4.0727 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 4.33 for the period ended March 31, 2022 as compared to Rs. 2.51 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 106.6909 crs | ₹87.4007 crs |  22.07% |
| Net Profit | ₹7.0302 crs | ₹4.0727 crs | 72.62% |
| EPS | ₹4.33 | ₹2.51 | 72.51% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 106.6909 crores during the period ended March 31, 2022 as compared to Rs.74.6739 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.7.0302 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.1.5497 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.4.33 for the period ended March 31, 2022 as compared to Rs.0.95 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 106.6909 crs | ₹74.6739 crs | 42.88% |
| Net Profit | ₹7.0302 crs | ₹1.5497 crs | 353.65% |
| EPS | ₹4.33 | ₹0.95 | 355.79% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.337.8295 crores during the Financial Year ended March 31, 2022 as compared to Rs.309.6002 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.14.5504 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.7.3175 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.8.96 for the Financial Year ended March 31, 2022 as compared to Rs.4.50 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹337.8295 crs | ₹309.6002 crs | 9.12% |
| Net Profit | ₹14.5504 crs | ₹7.3175 crs | 98.84% |
| EPS | ₹8.96 | ₹4.50 | 99.11% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 212.70 as compared to the previous close of Rs. 202.60. The total number of shares traded during the day was 4367 in over 32 trades.
The stock hit an intraday high of Rs. 212.70 and intraday low of 198.10. The net turnover during the day was Rs. 927587.00.
